US5628936A
(en)
*
|
1987-03-13 |
1997-05-13 |
Micro-Pak, Inc. |
Hybrid paucilamellar lipid vesicles
|
AU603659B2
(en)
*
|
1987-03-13 |
1990-11-22 |
Micro Vesicular Systems, Inc. |
Lipid vesicles formed of surfactants and steroids
|
US5234767A
(en)
*
|
1987-03-13 |
1993-08-10 |
Micro-Pak, Inc. |
Hybrid paucilamellar lipid vesicles
|
US5219538A
(en)
*
|
1987-03-13 |
1993-06-15 |
Micro-Pak, Inc. |
Gas and oxygen carrying lipid vesicles
|
US5474848A
(en)
*
|
1987-03-13 |
1995-12-12 |
Micro-Pak, Inc. |
Paucilamellar lipid vesicles
|
US5023086A
(en)
*
|
1987-03-13 |
1991-06-11 |
Micro-Pak, Inc. |
Encapsulated ionophore growth factors
|
US5147723A
(en)
*
|
1987-07-28 |
1992-09-15 |
Micro-Pak, Inc. |
Paucilamellar lipid vesicles
|
US5811119A
(en)
*
|
1987-05-19 |
1998-09-22 |
Board Of Regents, The University Of Texas |
Formulation and use of carotenoids in treatment of cancer
|
EP0324455A3
(de)
*
|
1988-01-15 |
1991-03-27 |
Hans O. Ribi |
Neue polymerische Immuno-Adjuvans
|
US4895452A
(en)
*
|
1988-03-03 |
1990-01-23 |
Micro-Pak, Inc. |
Method and apparatus for producing lipid vesicles
|
US5104736A
(en)
*
|
1988-03-03 |
1992-04-14 |
Micro-Pak, Inc. |
Reinforced paucilamellar lipid vesicles
|
US5013497A
(en)
*
|
1988-03-03 |
1991-05-07 |
Micro-Pak, Inc. |
Method and apparatus for producing lipid vesicles
|
US5032457A
(en)
*
|
1988-03-03 |
1991-07-16 |
Micro Vesicular Systems, Inc. |
Paucilamellar lipid vesicles using charge-localized, single chain, nonphospholipid surfactants
|
US5019174A
(en)
*
|
1988-03-03 |
1991-05-28 |
Micro Vesicular Systems, Inc. |
Removing oil from surfaces with liposomal cleaner
|
US5019392A
(en)
*
|
1988-03-03 |
1991-05-28 |
Micro-Pak, Inc. |
Encapsulation of parasiticides
|
US5160669A
(en)
*
|
1988-03-03 |
1992-11-03 |
Micro Vesicular Systems, Inc. |
Method of making oil filled paucilamellar lipid vesicles
|
US4906476A
(en)
*
|
1988-12-14 |
1990-03-06 |
Liposome Technology, Inc. |
Novel liposome composition for sustained release of steroidal drugs in lungs
|
US5510117A
(en)
*
|
1989-03-09 |
1996-04-23 |
Micro-Pak, Inc. |
Entrapment vehicle and method
|
GB8906234D0
(en)
*
|
1989-03-17 |
1989-05-04 |
Albright & Wilson |
Agrochemical suspensions
|
WO1991004013A1
(en)
*
|
1989-09-21 |
1991-04-04 |
Micro Vesicular Systems, Inc. |
Hybrid paucilamellar lipid vesicles
|
US5227165A
(en)
*
|
1989-11-13 |
1993-07-13 |
Nova Pharmaceutical Corporation |
Liposphere delivery systems for local anesthetics
|
US5188837A
(en)
*
|
1989-11-13 |
1993-02-23 |
Nova Pharmaceutical Corporation |
Lipsopheres for controlled delivery of substances
|
IE904098A1
(en)
*
|
1989-11-13 |
1991-05-22 |
Nova Pharm Corp |
Lipospheres for controlled delivery of substances
|
FR2657607B1
(fr)
*
|
1990-01-30 |
1992-04-30 |
Durand Muriel |
Procede de protection de la dihydroxyacetone, dihydroxyacetone protegee par ce procede et produit cosmetique contenant une telle dihydroxyacetone protegee.
|
US5213810A
(en)
*
|
1990-03-30 |
1993-05-25 |
American Cyanamid Company |
Stable compositions for parenteral administration and method of making same
|
US5165994A
(en)
*
|
1990-06-05 |
1992-11-24 |
University Of Delaware |
Spontaneous equilbrium surfactant vesicles
|
CA2046830C
(en)
|
1990-07-19 |
1999-12-14 |
Patrick P. Deluca |
Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
|
US6165500A
(en)
*
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
WO1992003123A1
(en)
*
|
1990-08-28 |
1992-03-05 |
Liposome Technology, Inc. |
Liposome alternative bilayer formulations
|
WO1992004010A1
(en)
*
|
1990-09-06 |
1992-03-19 |
S.C. Johnson & Son, Inc. |
Stabilized liposome process and compositions containing them
|
US5145604A
(en)
*
|
1990-09-19 |
1992-09-08 |
S. C. Johnson & Son, Inc. |
Aqueous emulsion and aerosol delivery system using same
|
US5091111A
(en)
*
|
1990-09-19 |
1992-02-25 |
S. C. Johnson & Son, Inc. |
Aqueous emulsion and aersol delivery system using same
|
US5256422A
(en)
*
|
1991-03-28 |
1993-10-26 |
Micro Vesicular Systems, Inc. |
Lipid vesicle containing water-in-oil emulsions
|
WO1992017179A1
(en)
*
|
1991-03-28 |
1992-10-15 |
Micro Vesicular Systems, Inc. |
Lipid vesicle containing water-in-oil emulsions
|
DE4121945C2
(de)
*
|
1991-07-03 |
1993-11-04 |
Merz & Co Gmbh & Co |
Verfahren zur herstellung von stabilen, hydrophilen oder ambiphilen creme-zubereitungen, enthaltend vesikulaere bestandteile, stabile creme-zubereitungen mit vesikulaeren bestandteilen und deren verwendung
|
US5213805A
(en)
*
|
1991-07-25 |
1993-05-25 |
Micro Vesicular Systems, Inc. |
Lipid vesicles having n,n-dimethylamide derivatives as their primary lipid
|
US5643600A
(en)
*
|
1991-09-17 |
1997-07-01 |
Micro-Pak, Inc. |
Lipid vesicles containing avocado oil unsaponifiables
|
US5260065A
(en)
*
|
1991-09-17 |
1993-11-09 |
Micro Vesicular Systems, Inc. |
Blended lipid vesicles
|
US5439967A
(en)
*
|
1991-09-17 |
1995-08-08 |
Micro Vesicular Systems, Inc. |
Propylene glycol stearate vesicles
|
US5405615A
(en)
*
|
1991-09-17 |
1995-04-11 |
Micro Vesicular Systems, Inc. |
Sucrose distearate lipid vesicles
|
EP0683673A4
(de)
*
|
1992-12-02 |
1996-06-26 |
Micro Vesicular Systems |
Antacidum mit verlängerter wirkdauer.
|
US5393527A
(en)
*
|
1993-01-04 |
1995-02-28 |
Becton, Dickinson And Company |
Stabilized microspheres and methods of preparation
|
CA2153780C
(en)
*
|
1993-01-15 |
2004-04-13 |
Micro Vesicular Systems, Inc. |
Method of inhibiting viral reproduction
|
US5853755A
(en)
*
|
1993-07-28 |
1998-12-29 |
Pharmaderm Laboratories Ltd. |
Biphasic multilamellar lipid vesicles
|
WO1995016437A1
(en)
*
|
1993-12-17 |
1995-06-22 |
Micro-Pak, Inc. |
Method of transmitting a biologically active material to a cell
|
ATE280585T1
(de)
*
|
1994-02-24 |
2004-11-15 |
Micro Pak Inc |
Impfstoffe, die paucilamelläre lipidvesikel als adjuvans enthalten
|
US20020048596A1
(en)
*
|
1994-12-30 |
2002-04-25 |
Gregor Cevc |
Preparation for the transport of an active substance across barriers
|
US5629021A
(en)
*
|
1995-01-31 |
1997-05-13 |
Novavax, Inc. |
Micellar nanoparticles
|
FR2730928B1
(fr)
*
|
1995-02-23 |
1997-04-04 |
Oreal |
Composition a base de vesicules lipidiques a ph acide et son utilisation en application topique
|
US5599548A
(en)
*
|
1995-05-08 |
1997-02-04 |
Elizabeth Arden Co., Division Of Conopco, Inc. |
Skin care compositions containing fatty acid amides and retinol or retinyl ester
|
US5954998A
(en)
*
|
1995-05-25 |
1999-09-21 |
The Clorox Company |
Liquid peracid precursor colloidal dispersions: oil-core vesicles
|
US5902604A
(en)
|
1995-06-06 |
1999-05-11 |
Board Of Regents, The University Of Texas System |
Submicron liposome suspensions obtained from preliposome lyophilizates
|
US5834014A
(en)
*
|
1995-10-06 |
1998-11-10 |
The Regents Of The University Of Michigan |
Stimulation of hair follicles
|
US5874105A
(en)
*
|
1996-01-31 |
1999-02-23 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
US6071535A
(en)
*
|
1996-01-31 |
2000-06-06 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
US6183774B1
(en)
|
1996-01-31 |
2001-02-06 |
Collaborative Laboratories, Inc. |
Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
|
US5662957A
(en)
*
|
1996-05-03 |
1997-09-02 |
Novavax, Inc. |
Oil containing lipid vesicles with marine applications
|
US5700679A
(en)
*
|
1996-06-07 |
1997-12-23 |
Novavax, Inc. |
Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
|
US5846551A
(en)
*
|
1996-06-10 |
1998-12-08 |
E-L Management Corp. |
Water-based makeup compositions and methods for their preparation
|
US5747051A
(en)
*
|
1996-09-27 |
1998-05-05 |
Elizabeth Arden Co., Division Of Conopco, Inc. |
Skin care compositions containing an amide of a hydroxy fatty acid and a retinoid
|
US5955092A
(en)
*
|
1996-09-27 |
1999-09-21 |
Elizabeth Arden Co., Division Of Conopco, Inc. |
Skin care compositions containing an n-substituted fatty acid amide and retinol or retinyl ester
|
US5935572A
(en)
*
|
1997-01-10 |
1999-08-10 |
Collaborative Laboratories, Inc. |
Composition containing protease separate from glycosidase for removing nits in treating lice infestation
|
US6039960A
(en)
*
|
1997-05-28 |
2000-03-21 |
E-L Management Corp. |
Water containing wax-based product
|
IS4518A
(is)
*
|
1997-07-09 |
1999-01-10 |
Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group |
Nýtt lyfjaform fyrir bóluefni
|
US5993852A
(en)
*
|
1997-08-29 |
1999-11-30 |
Pharmaderm Laboratories Ltd. |
Biphasic lipid vesicle composition for transdermal administration of an immunogen
|
TW476788B
(en)
|
1998-04-08 |
2002-02-21 |
Kimberly Clark Co |
A cleanser and the making process thereof
|
GB9824024D0
(en)
*
|
1998-11-03 |
1998-12-30 |
Unilever Plc |
Shampoo compositions
|
EP1140021B1
(de)
*
|
1998-12-23 |
2004-08-04 |
Idea Ag |
Verbesserte formulierung zur topischen, nichtinvasiven anwendung in vivo
|
DK1031346T3
(da)
|
1999-01-27 |
2002-08-12 |
Idea Ag |
Ikke-invasiv vaccination gennem huden
|
PT1031347E
(pt)
|
1999-01-27 |
2002-09-30 |
Idea Ag |
Transporte/imunizacao transnasal com veiculos muitissimo adaptaveis
|
US6080211A
(en)
*
|
1999-02-19 |
2000-06-27 |
Igen, Inc. |
Lipid vesicle-based fuel additives and liquid energy sources containing same
|
CA2309373A1
(en)
*
|
1999-05-27 |
2000-11-27 |
Johnson & Johnson Consumer Companies, Inc. |
Novel topical formulations
|
WO2001001962A1
(en)
*
|
1999-07-05 |
2001-01-11 |
Idea Ag. |
A method for the improvement of transport across adaptable semi-permeable barriers
|
US6309664B1
(en)
|
1999-09-15 |
2001-10-30 |
Igen, Incorporated |
Methods, uses and compositions of fluid petrolatum
|
US6534078B1
(en)
*
|
1999-10-18 |
2003-03-18 |
Natural Pest Fx, Inc. |
Micro-encapsulated pepper-mustard composition and methods of using the same
|
US6375968B1
(en)
|
1999-10-22 |
2002-04-23 |
3M Innovative Properties Company |
Encapsulated active material immobilized in hydrogel microbeads
|
US6376514B1
(en)
|
2000-10-17 |
2002-04-23 |
The Procter & Gamble Co. |
Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
|
US6540991B2
(en)
|
2001-04-06 |
2003-04-01 |
3M Innovative Properties Company |
Stabilized active materials
|
US6562361B2
(en)
|
2001-05-02 |
2003-05-13 |
3M Innovative Properties Company |
Pheromone immobilized in stable hydrogel microbeads
|
AU2002353774A1
(en)
*
|
2001-08-01 |
2003-03-24 |
The Procter And Gamble Company |
Products and methods for treating microbial infections
|
EP1423430A1
(de)
*
|
2001-08-16 |
2004-06-02 |
Lyfjathroun H.F., Biopharmaceuticals |
Verfahren zur ex-vivo-herstellung von antikörpern
|
US6709663B2
(en)
*
|
2001-08-31 |
2004-03-23 |
Healthpoint, Ltd. |
Multivesicular emulsion drug delivery systems
|
EP1304103B1
(de)
*
|
2001-10-22 |
2008-12-31 |
Viroblock SA |
Non-phospholipid Vesikel (npLV) und ihre Verwendung in kosmetischen, therapeutischen und prophylaktischen Anwendungen
|
US20030129213A1
(en)
*
|
2001-12-26 |
2003-07-10 |
Gonzalez Anthony D. |
Meta-stable insect repellent emulsion composition and method of use
|
US20030219465A1
(en)
*
|
2002-05-23 |
2003-11-27 |
Suresh Kumar Gidwani |
Composition for delivery of dithranol
|
US20030232091A1
(en)
*
|
2002-06-17 |
2003-12-18 |
Adi Shefer |
Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
|
US7473432B2
(en)
*
|
2002-10-11 |
2009-01-06 |
Idea Ag |
NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
|
US20040087564A1
(en)
*
|
2002-10-31 |
2004-05-06 |
Wright D. Craig |
Delivery composition and method
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
US7579455B2
(en)
|
2003-09-29 |
2009-08-25 |
Topigen Pharmaceutique Inc. |
Oligonucleotide compositions and methods for treating disease including inflammatory conditions
|
EP1754532B1
(de)
|
2004-04-05 |
2018-06-20 |
Kanagawa University |
Emulgierend wirkende dispergiermittel, verfahren zum emulgieren und dispergieren damit, emulsionen und emulsionsbrennstoffe
|
US8034796B2
(en)
*
|
2004-04-07 |
2011-10-11 |
The University Of Georgia Research Foundation, Inc. |
Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
|
MXPA06011475A
(es)
|
2004-04-07 |
2007-04-25 |
Univ Georgia Res Found |
Profarmacos, composiciones y metodos mutuos de glucosamina y glucosamina/antiinflamatorios.
|
JP4616602B2
(ja)
*
|
2004-09-16 |
2011-01-19 |
大日本塗料株式会社 |
単分散粒子の製造方法
|
CA2584457C
(en)
|
2004-10-29 |
2012-10-23 |
Topigen Pharmaceuticals Inc. |
Antisense oligonucleotides for treating allergy and neoplastic cell proliferation
|
CA2584475A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Idea Ag |
Extended surface aggregates in the treatment of skin conditions
|
US20120269886A1
(en)
|
2004-12-22 |
2012-10-25 |
Nitto Denko Corporation |
Therapeutic agent for pulmonary fibrosis
|
JP4533420B2
(ja)
*
|
2004-12-22 |
2010-09-01 |
日東電工株式会社 |
線維化抑制のための薬物担体および薬物担体キット
|
KR101454286B1
(ko)
|
2004-12-22 |
2014-10-27 |
닛토덴코 가부시키가이샤 |
섬유화 억제를 위한 약물 담체 및 약물 담체 키트
|
US20080045575A1
(en)
*
|
2004-12-29 |
2008-02-21 |
Van Dyke Thomas E |
Delivery of H2 Antagonists
|
JP4787818B2
(ja)
|
2005-01-28 |
2011-10-05 |
独立行政法人科学技術振興機構 |
脱水縮合反応により相転移を生じ得る分子集合体およびその相転移方法
|
US7470787B2
(en)
|
2005-07-11 |
2008-12-30 |
Aerie Pharmaceuticals, Inc. |
Isoquinoline compounds
|
WO2007041627A1
(en)
*
|
2005-10-03 |
2007-04-12 |
Pinsky Mark A |
Compositions and methods for improved skin care
|
CN103865892B
(zh)
|
2005-10-18 |
2017-04-12 |
诺瓦瓦克斯股份有限公司 |
功能性流感病毒样颗粒(vlp)
|
US9572886B2
(en)
|
2005-12-22 |
2017-02-21 |
Nitto Denko Corporation |
Agent for treating myelofibrosis
|
CA2652362C
(en)
*
|
2006-05-19 |
2014-10-07 |
Viroblock S.A. |
A composition for inactivating an enveloped virus
|
JP2009537118A
(ja)
*
|
2006-05-19 |
2009-10-29 |
トピジェン・ファーマシューティカルズ・インコーポレーテッド |
ホスホジエステラーゼの発現に影響するオリゴヌクレオチド
|
CA2664335C
(en)
*
|
2006-09-20 |
2014-12-02 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
CN101610749B
(zh)
*
|
2006-12-28 |
2013-01-02 |
3M创新有限公司 |
牙科填料及方法
|
US8455513B2
(en)
*
|
2007-01-10 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-aminoisoquinoline compounds
|
WO2008089408A1
(en)
*
|
2007-01-18 |
2008-07-24 |
Pinsky Mark A |
Materials and methods for delivering antioxidants into the skin
|
TWI407971B
(zh)
|
2007-03-30 |
2013-09-11 |
Nitto Denko Corp |
Cancer cells and tumor-related fibroblasts
|
EP3666284A1
(de)
|
2007-06-22 |
2020-06-17 |
Children's Medical Center, Corp. |
Verfahren und verwendungen von einem fragment von saposin a
|
FR2917976B1
(fr)
*
|
2007-06-29 |
2010-05-28 |
Galderma Sa |
Composition dermatologique comprenant des vehicules lipidiques de calcitriol, son procede de preparation et son utilisation
|
CA2693899A1
(en)
|
2007-07-19 |
2009-01-22 |
Novavax, Inc. |
Chimeric varicella zoster virus-virus like particles
|
ES2710498T3
(es)
*
|
2007-12-26 |
2019-04-25 |
Mark A Pinsky |
Formulaciones de colágeno para la mejora del cuidado de la piel
|
US8455514B2
(en)
*
|
2008-01-17 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-and 7-amino isoquinoline compounds and methods for making and using the same
|
US10251839B2
(en)
*
|
2008-01-22 |
2019-04-09 |
Igi Laboratories, Inc. |
Lipid vesicles derived from olive oil fatty acids
|
EP2285961A4
(de)
|
2008-05-15 |
2012-10-17 |
Topigen Pharmaceuticals Inc |
Oligonukleotide zur behandlung von entzündungen und neoplastischer zellvermehrung
|
RU2640249C2
(ru)
|
2008-05-23 |
2017-12-27 |
Сива Корпорейшн |
Способы, композиции и приборы для облегчения регенерации
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
US20110229544A1
(en)
*
|
2008-11-26 |
2011-09-22 |
Viroblock S.A. |
Methods for Inhibiting Gram-Postive Bacteria Using Non-Phospholipid Lipid Vesicules
|
AU2009333484B2
(en)
|
2008-12-09 |
2014-12-11 |
Novavax, Inc. |
Modified RSV F proteins and methods of their use
|
ES2553827T3
(es)
|
2009-05-01 |
2015-12-14 |
Aerie Pharmaceuticals, Inc. |
Inhibidores de mecanismo doble para el tratamiento de enfermedad
|
BR112012002084A2
(pt)
|
2009-07-29 |
2016-11-08 |
Univ Duke |
composições e métodos para inibir crescimento de pelo
|
US10143652B2
(en)
|
2009-09-23 |
2018-12-04 |
Curirx Inc. |
Methods for the preparation of liposomes
|
CA2781529C
(en)
|
2009-09-23 |
2017-10-24 |
Indu Javeri |
Methods for the preparation of liposomes comprising docetaxel
|
EP3366695B1
(de)
|
2009-12-17 |
2021-07-07 |
Children's Medical Center Corporation |
Aus saposin-a gewonnene peptide und verwendungen davon
|
US9649376B2
(en)
|
2010-09-27 |
2017-05-16 |
Siwa Corporation |
Selective removal of age-modified cells for treatment of atherosclerosis
|
SG190140A1
(en)
|
2010-11-05 |
2013-06-28 |
Novavax Inc |
RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPs)
|
US8721571B2
(en)
|
2010-11-22 |
2014-05-13 |
Siwa Corporation |
Selective removal of cells having accumulated agents
|
EP2646107A2
(de)
|
2010-12-01 |
2013-10-09 |
Spinal Modulation Inc. |
Wirkstofffreisetzungssysteme für selektive nervenmodulation
|
WO2012174446A1
(en)
|
2011-06-17 |
2012-12-20 |
President And Fellows Of Harvard College |
Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer
|
CN104023717B
(zh)
|
2011-06-29 |
2017-08-04 |
阿维达斯制药有限责任公司 |
包括脂质微胶囊递送媒剂的局部调配物和其用途
|
WO2013066438A2
(en)
|
2011-07-22 |
2013-05-10 |
President And Fellows Of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
US10736935B2
(en)
|
2011-12-22 |
2020-08-11 |
Children's Medical Center Corporation |
Saposin-A derived peptides and uses thereof
|
US9737480B2
(en)
|
2012-02-06 |
2017-08-22 |
President And Fellows Of Harvard College |
ARRDC1-mediated microvesicles (ARMMs) and uses thereof
|
AU2013203395A1
(en)
|
2012-03-30 |
2013-10-17 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for modulating TAU expression for reducing seizure and modifying a neurodegenerative syndrome
|
KR20150130430A
(ko)
|
2013-03-14 |
2015-11-23 |
아이시스 파마수티컬즈 인코포레이티드 |
타우 발현을 조절하는 조성물 및 방법
|
EP2968462B1
(de)
|
2013-03-15 |
2020-12-23 |
The Jackson Laboratory |
Verfahren zur förderung von wundheilung und haarwachstum
|
CN109528721B
(zh)
|
2013-03-15 |
2021-10-01 |
爱瑞制药公司 |
联合治疗
|
US20140325490A1
(en)
*
|
2013-04-25 |
2014-10-30 |
Hewlett-Packard Development Company, L.P. |
Classifying Source Code Using an Expertise Model
|
TW202246503A
(zh)
|
2013-07-19 |
2022-12-01 |
美商百健Ma公司 |
用於調節τ蛋白表現之組合物
|
US20150044192A1
(en)
|
2013-08-09 |
2015-02-12 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a cas9 nuclease
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
US9228207B2
(en)
|
2013-09-06 |
2016-01-05 |
President And Fellows Of Harvard College |
Switchable gRNAs comprising aptamers
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
CN105555306B
(zh)
|
2013-09-19 |
2019-12-03 |
诺瓦瓦克斯股份有限公司 |
免疫原性中东呼吸综合征冠状病毒(MERS-CoV)组合物和方法
|
US11053481B2
(en)
|
2013-12-12 |
2021-07-06 |
President And Fellows Of Harvard College |
Fusions of Cas9 domains and nucleic acid-editing domains
|
US20160310400A1
(en)
*
|
2013-12-23 |
2016-10-27 |
Dermopartners, S.L. |
Method for preparing liposomes of retinaldehyde or other precursors of retinoic acid and product thus obtained
|
AU2015298571B2
(en)
|
2014-07-30 |
2020-09-03 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
BR112017004169A2
(pt)
|
2014-09-03 |
2017-12-05 |
Boehringer Ingelheim Int |
composto direcionado à il-23a e ao tnf-alfa e usos do mesmo
|
KR102438295B1
(ko)
|
2014-09-19 |
2022-08-31 |
시와 코퍼레이션 |
염증 및 자가 면역 질환을 치료하기 위한 노화 방지 항체
|
US9816080B2
(en)
|
2014-10-31 |
2017-11-14 |
President And Fellows Of Harvard College |
Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
|
US9993535B2
(en)
|
2014-12-18 |
2018-06-12 |
Siwa Corporation |
Method and composition for treating sarcopenia
|
US10358502B2
(en)
|
2014-12-18 |
2019-07-23 |
Siwa Corporation |
Product and method for treating sarcopenia
|
US10487324B2
(en)
|
2015-02-25 |
2019-11-26 |
Washington University |
Methods to detect motor neuron disease comprising micro-RNAs
|
SG10201912593VA
(en)
|
2015-07-23 |
2020-02-27 |
Boehringer Ingelheim Int |
Compound targeting il-23a and b-cell activating factor (baff) and uses thereof
|
CN108697790B
(zh)
|
2015-09-03 |
2022-02-18 |
诺瓦瓦克斯股份有限公司 |
具有改进的稳定性和免疫原性的疫苗组合物
|
CA3000815C
(en)
|
2015-10-13 |
2022-11-01 |
Siwa Corporation |
Anti-age antibodies and methods of use thereof
|
JP7109784B2
(ja)
|
2015-10-23 |
2022-08-01 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
遺伝子編集のための進化したCas9蛋白質
|
US9643927B1
(en)
|
2015-11-17 |
2017-05-09 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
JP6832946B2
(ja)
|
2015-11-17 |
2021-02-24 |
アエリエ ファーマシューティカルズ インコーポレイテッド |
キナーゼ阻害剤およびその中間体の調製方法
|
PT3337829T
(pt)
|
2016-02-19 |
2020-02-10 |
Siwa Corp |
Método e composição para o tratamento do cancro, matando células cancerosas metastáticas e prevenindo as metástases do cancro usando anticorpos para produtos finais de glicação avançada (pga)
|
US10435682B2
(en)
|
2016-02-19 |
2019-10-08 |
University Of South Florida |
Arginine deiminase gene therapy for disordered proteins
|
WO2018191718A1
(en)
|
2017-04-13 |
2018-10-18 |
Siwa Corporation |
Humanized monoclonal advanced glycation end-product antibody
|
KR20180133452A
(ko)
|
2016-04-15 |
2018-12-14 |
시와 코퍼레이션 |
신경퇴행성 질환을 치료하기 위한 항-노화 항체
|
MX2018015254A
(es)
|
2016-06-08 |
2019-08-16 |
Childrens Medical Center |
Neurotoxinas botulinicas modificadas.
|
WO2017222535A1
(en)
|
2016-06-23 |
2017-12-28 |
Siwa Corporation |
Vaccines for use in treating various diseases and disorders
|
UA125965C2
(uk)
|
2016-07-08 |
2022-07-20 |
Чілдренс Медікал Сентр Корпорейшн |
Новий ботулінічний нейротоксин та його похідні
|
CN110214183A
(zh)
|
2016-08-03 |
2019-09-06 |
哈佛大学的校长及成员们 |
腺苷核碱基编辑器及其用途
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
CN106268551B
(zh)
*
|
2016-08-09 |
2018-11-20 |
中国石油大学(华东) |
一种具有光捕获功能的多级复合微胶囊的制备方法
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
EP3506890A1
(de)
|
2016-08-31 |
2019-07-10 |
Aerie Pharmaceuticals, Inc. |
Ophthalmische zusammensetzungen
|
JOP20190065A1
(ar)
|
2016-09-29 |
2019-03-28 |
Ionis Pharmaceuticals Inc |
مركبات وطرق لتقليل التعبير عن tau
|
US11730823B2
(en)
|
2016-10-03 |
2023-08-22 |
President And Fellows Of Harvard College |
Delivery of therapeutic RNAs via ARRDC1-mediated microvesicles
|
SG11201903089RA
(en)
|
2016-10-14 |
2019-05-30 |
Harvard College |
Aav delivery of nucleobase editors
|
AU2017382323B2
(en)
|
2016-12-23 |
2024-06-13 |
President And Fellows Of Harvard College |
Gene editing of PCSK9
|
US10745677B2
(en)
|
2016-12-23 |
2020-08-18 |
President And Fellows Of Harvard College |
Editing of CCR5 receptor gene to protect against HIV infection
|
US10995151B1
(en)
|
2017-01-06 |
2021-05-04 |
Siwa Corporation |
Methods and compositions for treating disease-related cachexia
|
US10961321B1
(en)
|
2017-01-06 |
2021-03-30 |
Siwa Corporation |
Methods and compositions for treating pain associated with inflammation
|
US10925937B1
(en)
|
2017-01-06 |
2021-02-23 |
Siwa Corporation |
Vaccines for use in treating juvenile disorders associated with inflammation
|
US10858449B1
(en)
|
2017-01-06 |
2020-12-08 |
Siwa Corporation |
Methods and compositions for treating osteoarthritis
|
EP3592853A1
(de)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Unterdrückung von schmerzen durch geneditierung
|
US20210196809A1
(en)
|
2017-03-09 |
2021-07-01 |
President And Fellows Of Harvard College |
Cancer vaccine
|
JP2020510439A
(ja)
|
2017-03-10 |
2020-04-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
シトシンからグアニンへの塩基編集因子
|
IL306092A
(en)
|
2017-03-23 |
2023-11-01 |
Harvard College |
Nucleic base editors that include nucleic acid programmable DNA binding proteins
|
SG11201908179UA
(en)
|
2017-03-31 |
2019-10-30 |
Aerie Pharmaceuticals Inc |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
WO2018209320A1
(en)
|
2017-05-12 |
2018-11-15 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
|
EP3658118A4
(de)
|
2017-07-24 |
2021-03-31 |
Novavax, Inc. |
Verfahren und zusammensetzungen zur behandlung von atemwegserkrankungen
|
EP3658573A1
(de)
|
2017-07-28 |
2020-06-03 |
President and Fellows of Harvard College |
Verfahren und zusammensetzungen zur entwicklung von basiseditoren unter verwendung von phagenunterstützter kontinuierlicher entwicklung (pace)
|
EP3676376A2
(de)
|
2017-08-30 |
2020-07-08 |
President and Fellows of Harvard College |
Hocheffiziente baseneditoren mit gam
|
EP3687566A2
(de)
|
2017-09-29 |
2020-08-05 |
Children's Medical Center Corporation |
Neurotoxinähnliches toxin und dessen verwendungen
|
CN111757937A
(zh)
|
2017-10-16 |
2020-10-09 |
布罗德研究所股份有限公司 |
腺苷碱基编辑器的用途
|
WO2019113210A1
(en)
|
2017-12-05 |
2019-06-13 |
Anthos Partners, Lp |
Phosphonium-based ionic drug conjugates
|
US11518801B1
(en)
|
2017-12-22 |
2022-12-06 |
Siwa Corporation |
Methods and compositions for treating diabetes and diabetic complications
|
US11254704B2
(en)
|
2018-01-05 |
2022-02-22 |
University Of South Florida |
Compounds and methods for reducing or inhibiting aggregation of proteins in a subject
|
US20220307001A1
(en)
|
2018-02-27 |
2022-09-29 |
President And Fellows Of Harvard College |
Evolved cas9 variants and uses thereof
|
US10507226B1
(en)
|
2018-05-02 |
2019-12-17 |
University Of South Florida |
N-amino peptide beta-sheet mimics for the treatment of Alzheimer's disease
|
EP3790595A4
(de)
|
2018-05-11 |
2022-06-08 |
Beam Therapeutics, Inc. |
Verfahren zum editieren von einzelnukleotidpolymorphismus unter verwendung von programmierbaren baseneditorsystemen
|
WO2019226953A1
(en)
|
2018-05-23 |
2019-11-28 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
WO2020023532A1
(en)
|
2018-07-23 |
2020-01-30 |
Siwa Corporation |
Methods and compositions for treating chronic effects of radiation and chemical exposure
|
US20240173430A1
(en)
|
2018-09-05 |
2024-05-30 |
The Broad Institute, Inc. |
Base editing for treating hutchinson-gilford progeria syndrome
|
WO2020056345A1
(en)
|
2018-09-14 |
2020-03-19 |
Aerie Pharmaceuticals, Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
US20220282275A1
(en)
|
2018-11-15 |
2022-09-08 |
The Broad Institute, Inc. |
G-to-t base editors and uses thereof
|
WO2020181202A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
A:t to t:a base editing through adenine deamination and oxidation
|
WO2020181180A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
A:t to c:g base editors and uses thereof
|
WO2020181195A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenine excision
|
WO2020181178A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through thymine alkylation
|
US20220170013A1
(en)
|
2019-03-06 |
2022-06-02 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenosine methylation
|
WO2020191241A1
(en)
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
WO2020210751A1
(en)
|
2019-04-12 |
2020-10-15 |
The Broad Institute, Inc. |
System for genome editing
|
EP3956349A1
(de)
|
2019-04-17 |
2022-02-23 |
The Broad Institute, Inc. |
Adeninbaseneditoren mit reduzierten off-target-effekten
|
WO2020236982A1
(en)
|
2019-05-20 |
2020-11-26 |
The Broad Institute, Inc. |
Aav delivery of nucleobase editors
|
WO2021025750A1
(en)
|
2019-08-08 |
2021-02-11 |
The Broad Institute, Inc. |
Base editors with diversified targeting scope
|
WO2021030666A1
(en)
|
2019-08-15 |
2021-02-18 |
The Broad Institute, Inc. |
Base editing by transglycosylation
|
US20230279373A1
(en)
|
2019-09-09 |
2023-09-07 |
Beam Therapeutics Inc. |
Novel crispr enzymes, methods, systems and uses thereof
|
WO2021072328A1
(en)
|
2019-10-10 |
2021-04-15 |
The Broad Institute, Inc. |
Methods and compositions for prime editing rna
|
WO2021108717A2
(en)
|
2019-11-26 |
2021-06-03 |
The Broad Institute, Inc |
Systems and methods for evaluating cas9-independent off-target editing of nucleic acids
|
KR20220123398A
(ko)
|
2019-12-03 |
2022-09-06 |
빔 테라퓨틱스, 인크. |
합성 가이드 rna, 이의 조성물, 방법 및 용도
|
WO2021155065A1
(en)
|
2020-01-28 |
2021-08-05 |
The Broad Institute, Inc. |
Base editors, compositions, and methods for modifying the mitochondrial genome
|
US20230235309A1
(en)
|
2020-02-05 |
2023-07-27 |
The Broad Institute, Inc. |
Adenine base editors and uses thereof
|
EP4100032A1
(de)
|
2020-02-05 |
2022-12-14 |
The Broad Institute Inc. |
Geneditierungsverfahren zur behandlung von spinaler muskelatrophie
|
WO2021222318A1
(en)
|
2020-04-28 |
2021-11-04 |
The Broad Institute, Inc. |
Targeted base editing of the ush2a gene
|
AU2021264007A1
(en)
|
2020-05-01 |
2022-12-08 |
Siwa Corporation |
Methods of treating infections
|
CA3177481A1
(en)
|
2020-05-08 |
2021-11-11 |
David R. Liu |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
WO2022093195A1
(en)
|
2020-10-27 |
2022-05-05 |
Siwa Corporation |
Methods and compositions for treating osteoarthritis using anti-age antibodies or age antigens
|
JP2023554540A
(ja)
|
2020-10-28 |
2023-12-27 |
ザ チルドレンズ メディカル センター コーポレーション |
切断型修飾組換えadamts13およびその使用
|
WO2022125776A2
(en)
|
2020-12-09 |
2022-06-16 |
Siwa Corporation |
Methods and compositions for treating kidney diseases
|
KR20230158476A
(ko)
|
2021-02-19 |
2023-11-20 |
빔 테라퓨틱스, 인크. |
유전자 요법을 위한 재조합 광견병 바이러스
|
CN117529555A
(zh)
|
2021-03-23 |
2024-02-06 |
比姆医疗股份有限公司 |
新颖crispr酶、方法、系统及其用途
|
WO2022221699A1
(en)
|
2021-04-16 |
2022-10-20 |
Beam Therapeutics, Inc. |
Genetic modification of hepatocytes
|
AU2022285744A1
(en)
|
2021-06-02 |
2023-12-14 |
Beam Therapeutics Inc. |
Circular guide rnas for crispr/cas editing systems
|
WO2022261509A1
(en)
|
2021-06-11 |
2022-12-15 |
The Broad Institute, Inc. |
Improved cytosine to guanine base editors
|
EP4373931A1
(de)
|
2021-07-23 |
2024-05-29 |
Beam Therapeutics Inc. |
Guide-rnas für crispr/cas-editiersysteme
|
CA3229602A1
(en)
|
2021-08-20 |
2023-02-23 |
Siwa Corporation |
Methods and compositions for treating fibrotic diseases
|
EP4399303A1
(de)
|
2021-09-08 |
2024-07-17 |
Beam Therapeutics, Inc. |
Virale guide-rna-abgabe
|
WO2023076898A1
(en)
|
2021-10-25 |
2023-05-04 |
The Broad Institute, Inc. |
Methods and compositions for editing a genome with prime editing and a recombinase
|
WO2023094435A1
(en)
|
2021-11-23 |
2023-06-01 |
Cellectis Sa |
New tale protein scaffolds with improved on-target/off-target activity ratios
|
CA3239498A1
(en)
|
2021-12-03 |
2023-06-08 |
David R. Liu |
Self-assembling virus-like particles for delivery of prime editors and methods of making and using same
|
AU2022400961A1
(en)
|
2021-12-03 |
2024-05-30 |
President And Fellows Of Harvard College |
Self-assembling virus-like particles for delivery of nucleic acid programmable fusion proteins and methods of making and using same
|
CA3240917A1
(en)
|
2021-12-17 |
2023-06-22 |
Bernd ZETSCHE |
Crispr enzymes, methzods, systems and uses thereof
|
WO2023196802A1
(en)
|
2022-04-04 |
2023-10-12 |
The Broad Institute, Inc. |
Cas9 variants having non-canonical pam specificities and uses thereof
|
WO2023196772A1
(en)
|
2022-04-04 |
2023-10-12 |
Beam Therapeutics Inc. |
Novel rna base editing compositions, systems, methods and uses thereof
|
WO2023205687A1
(en)
|
2022-04-20 |
2023-10-26 |
The Broad Institute, Inc. |
Improved prime editing methods and compositions
|
WO2023212715A1
(en)
|
2022-04-28 |
2023-11-02 |
The Broad Institute, Inc. |
Aav vectors encoding base editors and uses thereof
|
WO2023230613A1
(en)
|
2022-05-27 |
2023-11-30 |
The Broad Institute, Inc. |
Improved mitochondrial base editors and methods for editing mitochondrial dna
|
WO2023240137A1
(en)
|
2022-06-08 |
2023-12-14 |
The Board Institute, Inc. |
Evolved cas14a1 variants, compositions, and methods of making and using same in genome editing
|
WO2024040083A1
(en)
|
2022-08-16 |
2024-02-22 |
The Broad Institute, Inc. |
Evolved cytosine deaminases and methods of editing dna using same
|
WO2024059791A1
(en)
|
2022-09-16 |
2024-03-21 |
Beam Therapeutics Inc. |
Large serine recombinases, systems and uses thereof
|
WO2024077267A1
(en)
|
2022-10-07 |
2024-04-11 |
The Broad Institute, Inc. |
Prime editing methods and compositions for treating triplet repeat disorders
|
WO2024102157A1
(en)
|
2022-11-09 |
2024-05-16 |
Siwa Corporation |
Methods and compositions for treating diabetes and diabetic complications
|
WO2024138087A2
(en)
|
2022-12-23 |
2024-06-27 |
The Broad Institute, Inc. |
Methods and compositions for modulating cellular factors to increase prime editing efficiencies
|